The combined company will trade on the Nasdaq under the ticker OBX. It has also secured commitments for a private placement ...

As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial ...

For years, cell and gene therapies were mainly associated with rare and orphan diseases, those that impact small patient groups and lack effective treatment options. However, recent developments in ...

Imagine your immune cells could be modified to attack any kind of cancer. T cell receptor (TCR) therapy has the potential to one day become a universal cancer treatment. But there are risks.

T-cell therapy is the most efficacious approach for many patients with relapsed/refractory multiple myeloma, but it currently comes with 2 periods ...

Cell and gene therapies are moving towards correcting root causes of diseases. Let's take a look at future cell and gene therapy trends.

CAR-T cell therapy, originally developed for cancer, is showing ever more promise as a treatment for autoimmune diseases.

For the 40 million Americans living with diabetes, researchers are pursuing treatments that go beyond lifelong insulin injections. One emerging approach — reprogramming a patient’s own cells into ...

I f your doctor has recommended chimeric antigen receptor (CAR) T-cell immunotherapy for large B-cell lymphoma (LBCL), you’ve likely already tried several standard treatments, and the cancer did not ...

When stem cells are injected into thick tissues, they often clump together and die from lack of oxygen or nutrients, making it almost impossible to use them for thick, highly vascularized tissues like ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Cystic adenocarcinoma (marked in red) of the pancreas (outlined in green). Contrast‑enhanced ...